|4Dec 13, 4:26 PM ET

bioMerieux/ADR 4

4 · Quanterix Corp · Filed Dec 13, 2017

Insider Transaction Report

Form 4
Period: 2017-12-11
Transactions
  • Conversion

    Common Stock

    2017-12-11+2,055,6322,055,632 total
  • Conversion

    Series C Preferred Stock

    2017-12-116,606,8040 total
    Common Stock (2,055,632 underlying)
Footnotes (3)
  • [F1]The shares of preferred stock automatically converted into common stock immediately prior to the closing of the Issuer's initial public offering using a calculation defined in the Issuer's Restated Certificate of Incorporation, as amended, based on the initial purchase price and the conversion rate in effect at the time of conversion. The shares of preferred stock automatically converted on a 1-for-3.214 basis and such conversion rate is reflected in the amount of common stock underlying the security.
  • [F2]These shares were convertible into the Issuer's common stock in accordance with the Issuer's Restated Certificate of Incorporation, as amended, at any time after the issuance of such shares, at the holder's election.
  • [F3]Not applicable.

Documents

1 file
  • 4
    a4.xmlPrimary

    4